Light and the Body Clock: Timed Light, Light at Night and Blue-Blocking Glasses
Duffy 1996 (randomised trial) concludes that light is the primary synchronizer of the human circadian pacemaker; van Maanen 2016 (meta-analysis, 53 studies) reports light therapy effective for sleep problems overall, with most effect sizes small to medium; Xu 2022 reports higher light at night associated with a 22% higher prevalence of sleep problems; and the reviews of blue-blocking glasses differ, from substantial evidence of reduced sleep-onset latency (Hester 2021) to no significant difference from standard lenses (Lawrenson 2017).
- Loud snoring with witnessed gasping/choking or breathing pauses plus daytime sleepiness (possible obstructive sleep apnea), refer to a clinician
- Difficulty falling or staying asleep at least 3 nights/week for 3+ months with daytime impairment (possible chronic insomnia disorder), refer to a clinician
- Excessive daytime sleepiness despite adequate time in bed, or falling asleep involuntarily during activities, refer to a clinician
- Persistent inability to sleep/wake at socially desired times despite good habits (possible circadian rhythm sleep-wake disorder), refer to a clinician
What the evidence says
The sources on this entry studied light as a circadian cue: bright light compared with dim indoor light for entrainment, light therapy for sleep problems, light at night, and evening blue-blocking glasses. Duffy 1996 (randomised trial) reports that bright light exposure produced a significant phase shift in the core temperature rhythm while those without it did not significantly adapt, and concludes that behavioural cues such as sleep, activity, social contact and meal timing are relatively weak circadian synchronizers and that exposure to light is the primary synchronizer of the human circadian pacemaker. Wright 2005 (non-randomised trial) reports that five days of moderate bright light (about 450 lux) produced a shorter phase angle of entrainment than indoor daytime light (about 150 lux). On light therapy, van Maanen 2016 (meta-analysis, 53 studies, 1154 participants) reports it effective for sleep problems overall (g = 0.39), circadian rhythm disorders (g = 0.41), insomnia (g = 0.47) and dementia-related sleep problems (g = 0.30), with most effect sizes small to medium and an indication of publication bias. Faulkner 2019 (meta-analysis, 40 studies) reports that light interventions improved sleep continuity and self-reported sleep disturbance and advanced delayed sleep timing in psychiatric disorders, and calls the effects promising. Zhao 2025 (meta-analysis, 11 articles) reports that light therapy significantly improved total sleep time (MD 32.54) and sleep efficiency (MD 2.91) in shift workers. On light at night, Xu 2022 (meta-analysis of 7 cross-sectional studies, 577,932 participants) reports higher light-at-night exposure associated with a 22% higher prevalence of sleep problems, with indoor exposure showing a stronger effect than outdoor. Lu 2023 (meta-analysis, 13 publications) reports morning urinary melatonin metabolite significantly lower in night-shift workers exposed to nocturnal light than in those not exposed, and concludes that nocturnal light exposure inhibits melatonin secretion. On blue-blocking glasses the reviews differ. Hester 2021 (systematic review, 29 publications) reports substantial evidence that they reduce sleep-onset latency in sleep disorders, jet lag and shift work, with findings for depression heterogeneous and conflicting. Shechter 2020 (meta-analysis, 12 studies) reports small-to-medium effects on sleep efficiency and total sleep time and a large effect on Pittsburgh Sleep Quality Index ratings, and describes the evidence as “some, albeit mixed”. Lawrenson 2017 (systematic review of 3 randomised trials, 116 participants) reports no significant difference in sleep quality between blue-blocking and standard lenses and no high-quality trial evidence to support the claims.
- Do not claim to diagnose, treat, or cure insomnia, sleep apnea, or any sleep disorder
- Do not promise guaranteed, instant, or permanent improvements in sleep
- Do not present these general hygiene techniques as clinical therapy (e.g., CBT-I) or a substitute for medical care
- Agreement
- Direction recorded for 0 of 10 sources; not yet recorded for the rest.
- The claim's outcome
- Outcome not yet recorded
- Certainty
- No source states a certainty rating.
- Authors
- Sources share authors: C. Czeisler (senior author of 2 sources).
- How the sources were read
- Some sources are based on abstracts, not full texts.
What each source measured and concluded (10)
- What it measured
- Sleep and mood outcomes with evening blue-blocking glasses
- How it was read
- based on the abstract, not the full text
- What the review says it includes
- Systematic review
- Studies and participants, as stated
- 29 experimental publications (16 RCTs with 453 patients, plus uncontrolled trials, case series, case study, abstracts)
- Heterogeneity, as stated
- Substantial evidence that blue-blocking glasses reduce sleep onset latency in sleep disorders, jet lag, and shift work; 1 case study and 1 RCT in acute mania found substantial decreases in manic symptoms; findings for depression were heterogeneous and conflicting
- What it measured
- Nocturnal sleep quality and duration.
- How it measured it
- Objective measures (wrist accelerometry, PSG) and self-report measures (PSQI).
- How it was read
- read in full text
- What the review says it includes
- Systematic review and meta-analysis of 12 studies
- Heterogeneity, as stated
- Limitations: Small sample sizes affecting statistical power, heterogeneity in participant characteristics, variety of sleep assessment methods, difficulty in quantifying adherence to intervention.
- What it measured
- Phase angle of entrainment.
- How it measured it
- Dim light melatonin onset (DLMO) using radioimmunoassay (objective).
- How it was read
- read in full text
- What it measured
- Visual performance and visual fatigue.
- How it measured it
- Various visual performance tests (e.g., logMAR visual acuity, contrast sensitivity) and self-report questionnaires.
- Its conclusion, in its own words
- “The current systematic review did not identify any high quality clinical trial evidence to support these claims.”
- How it was read
- read in full text
- What the review says it includes
- Systematic review of 3 RCTs
- Studies and participants, as stated
- N=116 participants across 3 studies
- What it measured
- Phase shift in core temperature rhythm.
- How it measured it
- Rectal thermistor (objective).
- How it was read
- read in full text
- What it measured
- Effect of light therapy on sleep problems (Hedges' g effect sizes)
- How it was read
- screened only, not extracted
- What the review says it includes
- Systematic review and meta-analysis
- Studies and participants, as stated
- 53 studies, 1154 participants
- What it measured
- Sleep quality, duration, and timing following light interventions
- How it was read
- screened only, not extracted
- What the review says it includes
- Systematic review and meta-analysis of controlled studies
- Studies and participants, as stated
- 40 studies reporting 49 intervention comparisons
- What it measured
- Effect of nocturnal light exposure on melatonin (urinary aMT6s)
- How it was read
- screened only, not extracted
- What the review says it includes
- Meta-analysis
- Studies and participants, as stated
- 13 publications
- Heterogeneity, as stated
- Morning urinary aMT6s significantly lower in the exposed group than non-exposed (MD -3.69, 95%CI -5.41 to -1.98, P<0.0001), with no significant heterogeneity
- What it measured
- Association between light at night (LAN) exposure and sleep problems
- How it was read
- screened only, not extracted
- What the review says it includes
- Systematic review and meta-analysis of observational studies
- Studies and participants, as stated
- 7 cross-sectional studies; 577,932 participants
- What it measured
- Total sleep time (TST) and sleep efficiency (SE) with light therapy/phototherapy
- How it was read
- screened only, not extracted
- What the review says it includes
- Systematic review and meta-analysis (random-effects)
- Studies and participants, as stated
- 11 articles
Every source below is shown with its study design and links to the original study. This is the audit trail.
“Abstract only” means the review read that paper’s abstract, not its full text; “screened only” means it was included at re-screening and not extracted. Both stay in the trail with their DOI, because how a source was read is part of the audit.